Morgan E. Obrien - 07 Sep 2021 Form 4/A - Amendment Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
/s/Gena L. Ashe, attorney-in-fact
Issuer symbol
ATEX
Transactions as of
07 Sep 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
08 Jun 2022, 21:05:19 UTC
Date Of Original Report
08 Sep 2021
Previous filing
17 Aug 2021
Next filing
17 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +65,768 $0.000000 65,768 07 Sep 2021 Common Stock 65,768 $60.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prior Form 4 incorrectly reported the option grant for 65,595 shares.
F2 33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter.